Bear bile has been used in traditional Chinese medicine for thousands of years, valued primarily for treating liver and gallbladder disorders. The substance’s key active compound, ursodeoxycholic acid, has since become a mainstream pharmaceutical prescribed worldwide for specific liver conditions, though the version your doctor would prescribe today is made in a lab, not harvested from an animal. That gap between an ancient remedy and a modern drug, and the animal welfare crisis that sits between them, makes bear bile one of the more complicated stories in medicine.
The Compound That Gives Bear Bile Its Reputation
What makes bear bile medically interesting is a single molecule: ursodeoxycholic acid, usually abbreviated UDCA. The name literally means “bear bile acid” (from the Latin ursus, bear). Across six species of bears studied, UDCA made up anywhere from about 1% to 39% of biliary bile acids depending on the species. In other carnivores, including the giant panda, UDCA was either undetectable or present only in traces below half a percent.1PubMed. Ursodeoxycholic acid in the Ursidae: biliary bile acids of bears, pandas, and related carnivores This concentration is what originally gave bear bile its distinctive medicinal profile. No other readily available animal bile provided the same chemistry, which is why traditional practitioners considered it irreplaceable for centuries.
What Traditional Chinese Medicine Used It For
In traditional Chinese medicine, bear bile (known as xiongdan) has a documented history stretching back at least 1,300 years, with some references placing its use even earlier. Practitioners prescribed it mainly for liver and biliary complaints, but its traditional indications were broad. Bear bile appeared in formulations for reducing fever and inflammation, treating eye conditions like conjunctivitis, and addressing pain and swelling. It was classified as a “cold” medicine in TCM’s system of thermal properties, which made it a go-to remedy for conditions characterized by excess heat in the body.2PubMed Central. Bear bile: dilemma of traditional medicinal use and animal protection
The bile was typically dried into flakes or powder and incorporated into pills, ointments, or solutions. Whole dried gallbladders from wild bears were also traded as a premium product. For most of its history, the supply came from wild-hunted bears, which kept the material scarce and expensive. That scarcity partly drove the development of bear farming beginning in the 1980s, a practice that introduced its own set of problems.
Modern Pharmaceutical Uses for Liver Disease
UDCA’s jump from traditional remedy to Western pharmaceutical happened once researchers identified the specific compound and began testing it rigorously. The drug is now sold under the generic name ursodiol and several brand names, and it is approved for treating specific liver and biliary conditions. The most prominent is primary biliary cholangitis (formerly called primary biliary cirrhosis), a chronic autoimmune disease in which the bile ducts in the liver are slowly destroyed.
A landmark trial published in the New England Journal of Medicine followed patients with this condition for up to four years. Disease progressed far less frequently in the group receiving ursodiol compared to placebo. The probability of needing a liver transplant or dying was also significantly lower in the treated group.3PubMed. Ursodiol for the long-term treatment of primary biliary cirrhosis Based on this and subsequent trials, ursodiol became the standard first-line treatment for the disease and remains so today.
Ursodiol is also prescribed to dissolve certain types of cholesterol gallstones in patients who are not good candidates for surgery, and it is used to prevent gallstone formation in people losing weight rapidly (a known risk factor). In all these applications, the drug used is synthetic UDCA, identical to the molecule found in bear bile but manufactured without any animal involvement.
Research Beyond the Liver
While liver disease remains the established clinical use, researchers have been exploring UDCA and its derivatives for a surprisingly wide range of conditions. The most active area involves a related compound called tauroursodeoxycholic acid, or TUDCA, which is UDCA conjugated with the amino acid taurine. This is actually the form naturally present in bear bile, since bears conjugate their bile acids exclusively with taurine.
Protecting Cells From Programmed Death
UDCA has a remarkable ability to prevent cells from self-destructing through the process of programmed cell death. In laboratory studies, UDCA reduced apoptotic changes by 50 to 100% when cells were exposed to various agents that would normally trigger the self-destruct sequence.4PubMed Central. A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation The mechanism involves stabilizing mitochondrial membranes. Normally, when a cell receives signals to die, its mitochondria become leaky, releasing molecules that trigger a chain reaction ending in cell death. UDCA blocks this leakiness, preventing the release of a key trigger molecule by roughly 70 to 75%.5PubMed. Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation This anti-apoptotic effect works not only in liver cells but also in other cell types, which opened the door to investigating the compound for diseases far removed from the liver.
Brain and Nerve Protection
TUDCA has shown promise in animal models of neurological injury. In mice that experienced a type of brain hemorrhage, pretreatment with TUDCA improved blood flow in the brain, reduced leakage across the blood-brain barrier, and blocked a specific stress-response pathway in cells that normally leads to cell death. The treated mice showed significantly better neurological function afterward.6Brain Research. Tauroursodeoxycholic acid prevents ER stress-induced apoptosis and improves cerebral and vascular function in mice subjected to subarachnoid hemorrhage Similar preclinical work has explored TUDCA in models of Parkinson’s disease, Alzheimer’s disease, and amyotrophic lateral sclerosis (ALS), with varying degrees of encouraging results. These remain laboratory and animal findings, and human clinical trials are still limited for neurological applications.
A Possible Role Against Viral Infection
One of the more unexpected recent developments involves UDCA’s potential to reduce susceptibility to viral infections. Researchers found that a primary bile acid in the human body can upregulate the receptor that SARS-CoV-2 uses to enter cells. UDCA, working through a different mechanism, was able to counteract this effect in human tissue models derived from airways and intestines, reducing viral entry.7Acta Pharmaceutica Sinica B. Commentary: Can FXR serve as a potential target for COVID-19 prevention? This remains early-stage research and has not translated into clinical recommendations, but it illustrates how far UDCA’s reach may extend beyond the liver.
Synthetic Production and Why Bears Are No Longer Needed for Medicine
The pharmaceutical UDCA prescribed by doctors worldwide has not come from bears for decades. Multiple routes for synthesizing UDCA from cholic acid, a cheap and abundant bile acid from cattle, were developed as early as the 1980s. These methods combine enzymatic steps using bacterial enzymes with chemical reactions to convert cholic acid into UDCA.8PubMed. The enzymic and chemical synthesis of ursodeoxycholic and chenodeoxycholic acid from cholic acid The resulting product is chemically identical to what bears produce. There is no pharmacological reason to source UDCA from a bear.
More recently, researchers have been developing fully biological production methods that skip cattle bile entirely. One group engineered a strain of yeast that can convert the more widely available bile acid chenodeoxycholic acid (CDCA) into TUDCA through fermentation, providing what they describe as a sustainable and scalable approach.9PubMed Central. Biosynthesis of tauro-ursodeoxycholic acid (TUDCA) in Saccharomyces cerevisiae Another team engineered E. coli bacteria to carry out a multi-enzyme cascade that converts CDCA to UDCA in a single whole-cell reaction.10PubMed Central. Cost-effective whole-cell biosynthesis of ursodeoxycholic acid using engineered Escherichia coli with a multienzyme cascade These microbial platforms are still being optimized, but they point toward a future where UDCA production requires nothing more than bacteria and a feedstock.
Herbal Alternatives Within TCM
For practitioners and consumers who specifically want to stay within the TCM framework, there is growing evidence that certain medicinal plants can serve similar therapeutic roles. Research reviews have identified artificial bear bile, bile from other animals, synthetic compounds, and a range of medicinal plants as capable of matching bear bile’s therapeutic effects for the conditions it was traditionally prescribed for.11PubMed Central. Substitutes for Bear Bile for the Treatment of Liver Diseases: Research Progress and Future Perspective One detailed evaluation proposed six specific plant species, including gardenia, skullcap, goldthread, and rhubarb root, along with two traditional herbal formulations and two individual plant-derived compounds as alternatives. Many of these herbs were already commonly listed alongside bear bile in traditional formulations, just with different roles ascribed to them. The researchers concluded that the evidence for these herbal alternatives is strong enough that practitioners and consumers could use them without adding bear bile.12PubMed. Antiinflammatory and Hepatoprotective Medicinal Herbs as Potential Substitutes for Bear Bile
The Welfare Cost of Bile Farming
Despite the availability of synthetic alternatives, bear bile farming persists. The practice involves keeping bears in captivity and extracting bile repeatedly through surgically implanted catheters, free-dripping fistulas, or other invasive methods. The health consequences for the animals are severe and well-documented.
A study of 42 Asiatic black bears rescued from Vietnamese bile farms found that every single animal had chronic low-grade hepatobiliary inflammation. Beyond the direct damage to their livers and gallbladders, the chronic inflammatory environment from bile extraction, combined with poor living conditions, accelerated the development of age-related diseases. The rescued bears showed chronic kidney disease, muscle wasting despite obesity, cardiovascular changes, and degenerative joint disease at rates that suggested their bodies were aging far faster than normal.13Scientific Reports. Formerly bile-farmed bears as a model of accelerated ageing Separate examination of farmed bears confirmed that chronic cholecystitis (gallbladder inflammation) and chronic liver disease were universal findings across animals, with bacterial infection complicating many cases.14PLOS ONE. Chronic cholecystitis: Diagnostic and therapeutic insights from formerly bile-farmed Asiatic black bears (Ursus thibetanus)
The legal landscape is a patchwork. Bear farming remains legal in China, where roughly 7,000 bears are held on farms. South Korea banned bear farming in 1992, yet over 1,300 bears remained captive on farms as of recent counts, and bears over the age of ten could still be legally killed for their gallbladders. Vietnam agreed to phase out bear farming in 2005, but enforcement has been inconsistent. International trade in bear parts from wild bears is banned under wildlife trade agreements, though black markets persist between countries.
Why Farmed Bile Has Not Eliminated Demand for Wild Bears
One of the original arguments for bear farming was that a cheap, legal supply of farmed bile would reduce poaching pressure on wild bear populations. The evidence suggests this has not worked as hoped. A study modeling Chinese consumer preferences found that people were willing to pay considerably more for wild bear bile than for farmed, and that wild bile had low sensitivity to its own price changes. In other words, raising the price of wild bile did not do much to reduce demand for it.15PubMed Central. A stated preference investigation into the Chinese demand for farmed vs. wild bear bile
Even more troublingly, the researchers found that at prevailing prices, the availability of farmed bile as an alternative may have had close to zero effect on wild demand, or could even have the opposite effect, potentially increasing demand for the wild product. The reasoning is that when consumers have more choices, price becomes less of a factor in decision-making. The introduction of a cheaper farmed option may actually legitimize and draw attention to bear bile as a category, making the premium wild product more desirable to a subset of buyers.
A separate study examining consumer switching behavior found that preferences were mixed but fell into identifiable patterns. About a third of consumers in the sample were “law-abiding” and stuck with legal products. Just over half were “all-natural” consumers who disliked synthetic alternatives but might switch between farmed and wild bile. Only about 12% were non-consumers who preferred not to buy bile at all. Whether people had prior experience with bile consumption strongly shaped their preferences, and willingness to try wild products was linked to believing they were legal.16PubMed Central. Understanding why consumers in China switch between wild, farmed and synthetic bear bile products This suggests that clear legal messaging and accessible legal alternatives could shift some demand, but a large segment of the market actively resists moving away from animal-sourced products.
How Forensic Science Tracks Bear Bile in Trade
Enforcing trade bans requires being able to detect bear bile in products that may not be labeled honestly. Bear bile shows up in traditional medicine pills, ointments, wines, and even alcoholic spirits, sometimes in tiny quantities. Researchers have developed a DNA-based detection method sensitive enough to identify bear DNA in bile products even at extreme dilutions. The assay can distinguish among sun bears, Asiatic black bears, and American black bears, and it picks up as few as 10 copies of the target DNA sequence per reaction. In practical terms, adding a single drop of bear bile to a 750-milliliter bottle of alcohol still produces a clear detection signal, meaning dilutions of roughly 1 in 15,000 are within range.17Forensic Science International: Genetics. The bear necessities: A sensitive qPCR assay for bear DNA detection from bile and derived products to complement wildlife forensic enforcement Tools like this give wildlife enforcement officers a way to test products at borders and in markets without relying on labeling or seller claims.
Why Bears Produce So Much UDCA in the First Place
A question that rarely comes up in discussions of bear bile trade but is genuinely interesting: why do bears produce UDCA at concentrations that dwarf every other carnivore? The answer appears to be tied to hibernation. During months of winter dormancy, bears do not eat, drink, urinate, or defecate, yet they emerge in spring with remarkably preserved muscle mass. Most mammals would lose substantial muscle during that kind of inactivity.
Recent research found that while total bile acid levels in bear blood drop during hibernation, the ratio of secondary bile acids to primary bile acids actually increases. Bile acid metabolism remains active even while the rest of the animal’s metabolism slows dramatically. One compound in particular, taurolithocholic acid, showed a drastic increase during hibernation. Analysis of signaling pathways in bear muscle tissue showed that a bile-acid-driven pathway appears to stay active through the winter, likely helping maintain the energy-producing capacity of muscle cells and preserving their ability to function and regenerate.18Pflügers Archiv. Active bile acid metabolism could contribute to muscle preservation in hibernating bears via the TGR5 pathway In other words, bears may have evolved their unusual bile acid chemistry not for liver health but to survive months without moving. The medicinal properties that humans eventually discovered were, from the bear’s perspective, a side effect of solving a completely different biological problem.